http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CU-20200017-A7
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c35f3a3c112c482bcfa47356c4f80c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 |
| filingDate | 2018-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f85e00774f4a63fb92c9b2dff5014bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e109c8b2545bed8adc2653f6349744f |
| publicationDate | 2020-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CU-20200017-A7 |
| titleOfInvention | STABLE SOLID, LYOPHILIZED, CONTAINING WITH PALISIB SUITABLE FOR DILUTION AND THERAPEUTIC APPLICATIONS, AS WELL AS A METHOD FOR ITS RECONSTITUTION |
| abstract | <p> The present invention relates to: <br /> • a method for preparing an aqueous, "bulk solution", containing copanlisib, stable suitable for lyophilization and for therapeutic applications, (hereinafter referred to as "manufacturing process"); <br /> • a bulk solution, containing copanlisib, stable, (hereinafter called "bulk solution"), of higher solubility which is directly suitable for lyophilization; <br /> • a method for lyophilizing said bulk solution, (hereinafter referred to as the "lyophilization process"); </p> <p> • a stable, lyophilized solid containing copanlisib, in particular powder or cake, that <br /> particularly contains a therapeutic dose of copanlisib in one or two containers, <br /> particularly in a sealed container, (hereinafter referred to as a "lyophilisate"); <br /> • a method for reconstituting said lyophilisate, (hereinafter referred to as a "lyophilisate "); and <br /> • a stable, reconstituted solution containing copanlisib of greater solubility, suitable for further dilution and for therapeutic applications, (hereinafter referred to as "reconstituted solution"). </p> <p> </p> <p> </p> |
| priorityDate | 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565596 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421012904 |
Total number of triples: 29.